Research highlights IBS drugs offering best risk-benefit odds - ProHealth
|
Based on analysis of more than two dozen major clinical trials, two well-studied drug therapies – rifaximin and lubiprostone – offer irritable bowel syndrome (IBS) patients the best odds of benefit without harmful side effects, according to research led by the GI Motility Lab at Cedars-Sinai Medical Center in New York. ... Besides Cedars-Sinai, other centers participating in the research included the School of Medicine at Texas Tech University’s Health Sciences Center; the UCLA Department of Medicine; Beth Israel Deaconess Medical Center; and Harvard Medical School. Funding for the study was provided by the Beatrice and Samuel A. Seaver Foundation. Read the full story >> |
Related Stories
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
A Rite of Passage for Next Generation of Physicians
Students in TTUHSC's School of Medicine Class of 2028 received their first white coat and pledged their commitment to the medical profession at the White Coat Ceremony Friday (July 26) at the Buddy Holly Hall of Performing Arts and Sciences.
How Does Your Garden Grow?
As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.
Recent Stories
'Tis the Season: Flu, RSV and COVID-19
Koy Kubala, DCLS, spoke about the increase we see in these infections during this season, how we can proactively avoid them, and what treatment can help at the onset of symptoms.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Unlock a Better Nursing Future
Texas Tech University Health Sciences Center (TTUHSC) is streamlining the path to doctoral-level, specialized education for nurses.